The ROE as of December 2024 (TTM) for IO Biotech, Inc. (IOBT) is -86.56%

According to IO Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is -86.56%. This represents a change of 280.09% compared to the average of -22.77% of the last 4 quarters.

IO Biotech, Inc. (IOBT) Historical ROE (quarterly & annually)

How has IOBT ROE performed in the past?

The mean historical ROE of IO Biotech, Inc. over the last ten years is -13.65%. The current -86.56% ROE has changed 533.92% with respect to the historical average. Over the past ten years (40 quarters), IOBT's ROE was at its highest in in the March 2020 quarter at 238.65%. The ROE was at its lowest in in the March 2021 quarter at -143.99%.

IO Biotech, Inc. (IOBT) ROE by Quarter and Year

Discovering the peaks and valleys of IO Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IO Biotech, Inc. (IOBT) Average ROE

How has IOBT ROE performed in the past?

The current ROE of IO Biotech, Inc. (IOBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IO Biotech, Inc. (IOBT) ROE vs. Peers

How is IOBT’s ROE compared to its peers?

IO Biotech, Inc.’s ROE is greater than PMV Pharmaceuticals, Inc. (-24.20%), less than Eliem Therapeutics, Inc. (0%), greater than MediciNova, Inc. (-20.70%), greater than Pharvaris N.V. (-38.27%), greater than PepGen Inc. (-60.17%), greater than Pardes Biosciences, Inc. (-41.86%), greater than Shattuck Labs, Inc. (-61.92%), less than Champions Oncology, Inc. (66.22%), greater than Century Therapeutics, Inc. (-66.58%), greater than Structure Therapeutics Inc. (-16.40%), greater than Erasca, Inc. (-42.26%), less than ASLAN Pharmaceuticals Limited (543.83%), greater than Lyra Therapeutics, Inc. (-178.68%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than NewAmsterdam Pharma Company N.V. (-53.79%), less than Inventiva S.A. (524.89%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Compass Therapeutics, Inc. (-32.37%), greater than Design Therapeutics, Inc. (-18.01%), greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Ikena Oncology, Inc. (-39.59%), greater than Stoke Therapeutics, Inc. (-54.45%),

Build a custom stock screener for IO Biotech, Inc. (IOBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IO Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IO Biotech, Inc. (IOBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IO Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.